Navigation Links
FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of the neuroimmune axis and its role in disease processes. The importance of the neuroimmune axis in disease pathophysiology and therapies will be discussed for benchmark nervous system disorders, such as multiple sclerosis and spinal cord injury.

In addition, emerging areas where the importance of the neuroimmune axis has only recently been recognized, such as neuropsychiatric disorders, lysosomal storage diseases and axonal regeneration will be discussed. This FASEB Conference brings together physician-scientists and basic scientists as well as postdoctoral and graduate trainees for presentations and one-on-one discussions to broaden our understanding of fundamental aspects of disease mechanisms and therapeutic strategies in a highly collaborative and collegial environment.

A new training component associated with this conference will include a one day pre-meeting course on neuroimmunology, with material crafted to coincide with the major scientific topics covered during the main meeting. The interdisciplinary nature of this conference arises from an understanding that neuroimmune processes are intimately linked to the pathophysiology of numerous nervous system disorders, and through understanding the cellular and molecular mechanisms of these pathologies, more effective therapies may be realized. The conference is attended by immunologists, neuroscientists, neuroimmunologists, physicians and physician-scientists and is the only long-standing specialized conference held in North America to regularly attract members from each of these related, but distinct disciplines.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
2. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
3. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
4. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
5. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
6. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
7. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
8. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
9. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
10. FASEB announces BioArt image and video competition winners
11. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
(Date:12/15/2016)... 2016 "Increase in mobile transactions is driving ... biometrics market is expected to grow from USD 4.03 ... at a CAGR of 29.3% between 2016 and 2022. ... growing demand for smart devices, government initiatives, and increasing ... component is expected to grow at a high rate ...
(Date:12/7/2016)... BioCatch , the global leader in behavioral biometrics, reported a ... over 40 granted and pending patents. ... , The Company,s IP portfolio expansion ... Device, and Method Estimating Force Applied to a Touch Surface, " ... components needed to estimate the force and pressure applied to touch surfaces ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... (PRWEB) , ... January 12, 2017 , ... ... to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months ... a new drug combination that has stabilized Rosendahl’s disease and increased both the ...
(Date:1/12/2017)... MERIDEN, Conn. , Jan. 12, 2017 /PRNewswire/ ... development company and maker of Flublok Influenza ... based Zika vaccine candidate had good safety results ... virus in preclinical studies. The product is expected ... next few months.  In addition, the Institute of ...
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock ... Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated to ... 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... journal Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib ... a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients ...
Breaking Biology Technology: